Hepatocellular carcinoma, a rapidly increasing public health problem: the Tulane experience 2003-2009

Naveen Kumar R Tangutur1, Sabeen Faruqui Medvedev, Fred Regenstein

  • 1Section of Gastroenterology and Hepatology, Tulane University Health Sciences Center, New Orleans, USA.

Insights

Hepatocellular carcinoma (HCC) cases increased 300% at Tulane University Medical Center from 2003-2009, mirroring national trends. Hepatitis C virus (HCV) and diabetes are key risk factors, necessitating early detection programs.

Area of Science:

  • Hepatology
  • Oncology
  • Public Health

Background:

  • Hepatocellular carcinoma (HCC) incidence and mortality are rising nationally, with Louisiana experiencing particularly high mortality rates.
  • Understanding local trends and risk factors for HCC is crucial for public health interventions.

Purpose of the Study:

  • To review the experience with HCC at Tulane University Medical Center between 2003 and 2009.
  • To compare local HCC trends with national data.
  • To identify potential risk factors contributing to HCC development.

Main Methods:

  • Retrospective review of HCC cases at Tulane University Medical Center from 2003 to 2009.
  • Comparison of institutional data with national HCC incidence and mortality statistics.

Main Results:

  • A 300% increase in new HCC cases was observed at Tulane University Medical Center during the study period, aligning with national trends.
  • Hepatitis C virus (HCV) infection leading to cirrhosis was identified as the most common risk factor for HCC.
  • Preliminary data suggests a potential role for diabetes in HCC development.

Conclusions:

  • The study confirms a significant rise in HCC incidence in Louisiana.
  • Early detection and surveillance programs for individuals at risk are strongly recommended.
  • Further research into the role of diabetes in HCC pathogenesis is warranted.

Related Concept Videos